comparisonMOTS-c is a 16-amino acid mitochondrial-derived peptide that also activates AMPK. Unlike AICAR, MOTS-c is an actual peptide, encoded by mitochondrial DNA and naturally produced in response …
Source: seekpeptides.comOpen reference →comparison5-amino-1MQ is another compound of interest in metabolic research, though it works through NNMT inhibition rather than AMPK activation. While both compounds address metabolic dysfunction, t…
Source: seekpeptides.comOpen reference →comparisonGW501516 is the other compound from the Salk Institute study. It works through PPARdelta activation rather than AMPK. While both are classified as exercise mimetics, they target different m…
Source: seekpeptides.comOpen reference →comparisonSS-31 (elamipretide) targets mitochondria directly by stabilizing cardiolipin in the inner mitochondrial membrane. While AICAR tells cells to make more mitochondria through AMPK and PGC-1al…
Source: seekpeptides.comOpen reference →comparisonMetformin, the most widely prescribed diabetes medication globally, also activates AMPK but through a completely different mechanism. Metformin inhibits complex I of the mitochondrial elect…
Source: seekpeptides.comOpen reference →comparisonAICAR does not exist in isolation. Multiple compounds target AMPK or produce exercise-mimetic effects. Understanding how AICAR compares to alternatives helps researchers make informed decisions.
Source: seekpeptides.comOpen reference →